Sources

15 Total Sources

Abbott Raises 2026 EPS View to $5.45-$5.60 as Q2 Sales Climb 13%

Left20%

Center60%

Right20%

PR Newswire1d ago

Abbott Reports Q2 2026 Results, Raises Full-Year EPS Guidance

StockTitan1d ago

Abbott Q2 Earnings: EPS Guidance Raised to $5.45-$5.60 | ABT Stock News

Abbott Laboratories (NYSE:ABT) Surprises With Q2 CY2026 Sales

Abbott (ABT|$155.0B) - 2026 Q2 Earnings Analysis

scanx.trade21h ago

Abbott Reports Q2 2026 Results, Raises Full-Year Adjusted EPS Guidance to $5.45–$5.60

Abbott rises 4% after earnings beat and higher full-year profit guidance | XTB

Marketscreener.com1d ago

Abbott Reports Second-Quarter 2026 Results and Raises Full-Year EPS Guidance | MarketScreener

GuruFocus.com1d ago

Abbott Laboratories (ABT) Reports Strong Q2 Results and Raises F

🔥Stocks moving after the bell $ABT Abbott Reports Second-Quarter 2026 Results and Raises Full-Year EPS Guidance

Abbott Laboratories Stock (ABT) Rallies on a Q2 Earnings Beat and a 2026 EPS Guidance Increase - TipRanks.com

Abbott's Q2 2026 earnings call: What drove results and what should investors watch next? | Abbott Newsroom

Yahoo Finance1d ago

Abbott Laboratories (NYSE:ABT) Surprises With Q2 CY2026 Sales

Abbott raises 2026 profit forecast on strength in diagnostics, medical devices - AOL

levelfields.ai1d ago

LevelFields — Abbott Rises After Earnings Beat and Raised EPS Guidance

Seeking Alpha1d ago

Abbott Laboratories: Double Beat And Raise Surprises The Street (Rating Upgrade) (ABT) | Seeking Alpha